Denmark vs Pre-demographic dividend: Antiretroviral therapy coverage
Denmark
92.0%
in 2023
Pre-demographic dividend
82.2%
in 2024
Denmark rank
14th
Pre-demographic dividend rank
11th
Antiretroviral therapy coverage over time
- Denmark
- Pre-demographic dividend
How they compare
Denmark currently reports 92.0% against 82.2% in Pre-demographic dividend, a difference of 9.8%.
That makes Denmark's figure about 1.1 times Pre-demographic dividend's.
Across all 24 years both countries report, Denmark has been ahead every year.
Denmark ranks 14th and Pre-demographic dividend ranks 11th of 143 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Pre-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.8% | 5.1% | 44.7% | Denmark |
| 2010s | 77.6% | 41.8% | 35.8% | Denmark |
| 2020s | 90.2% | 72.7% | 17.5% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Denmark or Pre-demographic dividend?
- Denmark, at 92.0% against 82.2% in Pre-demographic dividend as of 2023.
- What is the difference in antiretroviral therapy coverage between Denmark and Pre-demographic dividend?
- 9.8%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Pre-demographic dividend?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Pre-demographic dividend rank globally for antiretroviral therapy coverage?
- Denmark ranks 14th and Pre-demographic dividend ranks 11th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.